Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome-Reference-Cited by-同舟云学术

Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome

Published:2001 Issue:4 Volume:68 Page:237-245
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Lee Seung Tae,Jang Joon Ho,Suh Hyung Chan,Hahn Jee Sook,Ko Yun Woong,Min Yoo Hong

Publisher

Wiley

Subject

Hematology

Reference39 articles.

1. Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia

2. Bone marrow transplantation for acute myelogeous leukemia: recent advances. In: editors, Bone marrow transplantation: current controversies. New York: Alan R Liss; 1989. p 95-106.

3. High-dose cytosine arabinoside therapy for refractory leukemia

4. PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIAL

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spinal Cord Stimulation in Special Populations: Best Practices from the American Society of Pain and Neuroscience to Improve Safety and Efficacy;Journal of Pain Research;2022-10

2. Thrombopoiesis-stimulating agents and myelodysplastic syndromes;British Journal of Haematology;2015-02-06

3. Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia;Leukemia & Lymphoma;2015-01-21

4. The effect of decitabine on megakaryocyte maturation and platelet release;Thrombosis and Haemostasis;2011

5. Thrombocytopenia in Patients With Myelodysplastic Syndromes;Seminars in Hematology;2010-07